期刊文献+

持续温热腹腔灌注对大鼠外周血NK细胞活性和腹腔器官的影响 被引量:2

Effects of Continuous Intraperitoneal Hyperthermic Perfusion on Peripheral NK Cytolytic Activity and Peritoneal Viscera in Rats
下载PDF
导出
摘要 通过在大鼠建立温热灌注模型,研究了(42±1)℃、1h温热生理盐水腹腔持续灌注对外周血NK细胞活性和腹腔内器官的影响。结果发现温热灌注后外周血NK细胞活性短暂上升,2周时恢复正常。术后2周内可见脾小体普遍增大,动脉周围淋巴鞘增宽。腹腔内无明显粘连。肝、肾无肉眼可见病变。术后1d时血浆谷丙转氨酶显著升高,2周内恢复。白蛋白术后下降较快。术后1d时镜下见肝浅层细胞胞浆疏松化,5d时正常。2(2/10)例术后1d时肠粘膜糜烂,2周可恢复。结果表明(42±1)℃、1h腹腔温热灌注可增强大鼠NK细胞杀伤活性,对术后早期抗肿瘤免疫可产生有利影响。同时对大鼠腹内器官损伤作用轻微。易受热损伤的器官为肠粘膜及肝脏。 An animal model of intraperitoneal hyperthermic per fusion was established in Rats. Investigation was carried out to recognize the effects of 42±1℃, 1 hr. peritoneal perfusion on peripheral natural killer cytolytic activity and injuries to peritoneal viscera. It was found that activity of NK cells rose on day 5after hyperthermia and went down to normal in the 2nd week. Lymph nodules in the spleen showed difusive hypertrophy and the periarterial lymphocyte sleeve widened in 2 weeks- Peritoneal adhesion was not observed. Serum GPT level jumped up on day 1 and stepped down nearly to normal in 2 weeks. Serum albumin level was significantly decreased. Accordingly, cells close to liver capsule swelled balloon-likely on day 1 after hyperthermia and recovered by day 5. Two Rats showed intestinal mucosa erosive lesions on day 1 after hyperthermia, but no lesions were observed in the 2nd week. These results showed that 42±1℃, 1 hr. in traperitoneal perfusion could enhance the cytolytic activity of NK cells. Beneficial effect on early postoperative antitumor immunity could be obtained from this event. It was also proved that injuries to abdominal organs were not severe during the 42±1℃, 1 hr. intraperitoneal hyperthermia. Organs susceptible to heat are intestinal mucosa and liver.
出处 《同济医科大学学报》 CSCD 1997年第2期102-104,108,共4页 Acta Universitatis Medicinae Tongji
基金 湖北省卫生厅资助!3-62~#
关键词 灌注法 局部 NK细胞 活性 热损伤 肿瘤 perfusion regional NK cytolytic activity hyperthermic injuries
  • 相关文献

参考文献1

共引文献22

同被引文献31

  • 1贾筱琴,王正兵,陈兵,李厚达.重组TRAIL抑制7402肝癌细胞生长的实验研究[J].实用临床医药杂志,2004,8(6):22-24. 被引量:5
  • 2米登海,陈学鹏,石远凯.腹腔内化疗治疗恶性腹水[J].国际肿瘤学杂志,2006,33(11):854-857. 被引量:10
  • 3虞喜豪,李新娉,周建梁,王建平,王革芳.腹腔化疗联合腹部透热全身热疗治疗恶性腹水的临床观察[J].临床内科杂志,2007,24(4):253-255. 被引量:9
  • 4刘志敏,康琳,刘义冰,吕雅蕾.腹腔热灌注顺铂治疗恶性腹水的临床观察[J].肿瘤,2007,27(6):508-508. 被引量:16
  • 5魏红梅,郭坤元,梅家转,常红,宋朝阳,邓兰,牛新青.热疗联合化疗对K562/AO2细胞体外作用的实验研究[J].中国实验血液学杂志,2007,15(4):724-728. 被引量:8
  • 6Arnmouri L, Promrner EE. Palliative treatment of malignant ascites: profile of catumaxomab. Biologics 2010, 4:103-110 [PMID: 20531969 DOI: 10.2147/ BTT.S6697].
  • 7Levine EA, Stewart JH, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg 2007, 204: 943-953, discussion 953-955 [PMID: 17481516 DOI: 10.1016/ j.jamcollsurg.2006.12.048].
  • 8Glehen O, Mithieux F, Osinsky D, Beaujard AC, Freyer G, Guertsch P, Francois Y, Peyrat P, Pan- teix G, Vignal J, Gilly FN. Surgery combined with peritonectomy procedures and intraperitoneal che- mohyperthermia in abdominal cancers with perito- neal carcinornatosis: a phase II study. J Clin Oncol 2003, 21:799-806 [PMID: 12610177 DOI: 10.1200/ JCO.2003.06.139].
  • 9Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN. Intraperitoneal chemohyperther- mia and attempted cytoreductive surgery in pa- tients with peritoneal carcinomatosis of colorectal origin. Br J Surg 2004, 91:747-754 [PMID: 15164446 DOI: 10.1002/bjs.4473].
  • 10de Bree E, Koops W, KrOger R, van Ruth S, Verwaal VJ, Zoetmulder FA. Preoperative computed to- mography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2006, 32:65-71 [PMID: 16290055 DOI: 10.1016/j.ejso.2005.09.016].

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部